who shouldn't take glp 1 GLP-1 Safety: Use These Medications Some people taking GLP-1 weight

Additionally, treatment with Liraglutide was associated with reduced mean baseline urinary sodium, extracellular volume, natriuresis, N-terminal pro b-type natriuretic peptide (NT-proBNP) and urinary albumin excretion rate, all of which are indicative of its beneficial effects on renal function [87]

The STEP 1 trial reported waist circumference reductions of approximately 9-10 cm with semaglutide 2.4 mg, while the SURMOUNT-1 trial showed reductions of 14-18 cm with tirzepatide, depending on dose

Welcome to Novo Nordisk Science Hub Are you a healthcare professional

From assessment to your door in 35 days Complete your assessment 3-minute medical intake online

"I think it looks horrible," admitted the star to podcast host Julia Louis-Dreyfus

It's also the dietary approach commonly recommended for people taking GLP-1 medications such as semaglutide or tirzepatide to improve treatment outcomes and reduce digestive side effects